Spinal Cord Ependymomas With MYCN Amplification Show Aggressive Clinical Behavior

Amy A. Swanson, Aditya Raghunathan, Robert Brian Jenkins, Martina Messing-Jünger, Torsten Pietsch, Michelle J. Clarke, Timothy J Kaufmann, Caterina Giannini

Research output: Contribution to journalArticle

Abstract

Adult spinal cord ependymomas are typically low grade and have a relatively favorable clinical course following gross total resection. We report 4 cases of anaplastic spinal cord ependymoma with MYCN amplification, an exceptionally rare finding. All cases occurred in the spinal cord of adolescent and young adult women and had morphological and immunohistochemical features of anaplastic ependymomas (World Health Organization grade III). Chromosomal microarray analysis demonstrated amplification of 2p24 (including MYCN) in all cases. One patient died 6 months after surgery. Another patient recently had removal of metastatic nodules in the thoracic region, following gross total resection and adjuvant radiation therapy of a lumbar ependymoma 1 year previously. One patient responded well after chemotherapy but died after multiple relapses 82 months after diagnosis. We found MYCN amplification reported in 2 other ependymomas, both anaplastic and arising in the spinal cord of adult females (Brain Pathol 2001;11:133-43). One patient had multiple recurrences in the spinal cord and an intracranial metastasis. Although MYCN amplification is rare in ependymomas, the current and previously reported cases suggest that this is associated with higher-grade histology, spinal location, and often unfavorable prognosis. The clinical significance and therapeutic implications of MYCN amplification in ependymomas require further evaluation.

Original languageEnglish (US)
Pages (from-to)791-797
Number of pages7
JournalJournal of neuropathology and experimental neurology
Volume78
Issue number9
DOIs
StatePublished - Sep 1 2019

Fingerprint

Ependymoma
Spinal Cord
Recurrence
Microarray Analysis
Young Adult
Histology
Radiotherapy
Thorax
Neoplasm Metastasis
Drug Therapy
Brain

Keywords

  • Anaplastic ependymoma
  • Ependymoma
  • MYCN amplification
  • Spinal cord

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Neurology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

Spinal Cord Ependymomas With MYCN Amplification Show Aggressive Clinical Behavior. / Swanson, Amy A.; Raghunathan, Aditya; Jenkins, Robert Brian; Messing-Jünger, Martina; Pietsch, Torsten; Clarke, Michelle J.; Kaufmann, Timothy J; Giannini, Caterina.

In: Journal of neuropathology and experimental neurology, Vol. 78, No. 9, 01.09.2019, p. 791-797.

Research output: Contribution to journalArticle

@article{b7bb7ce183aa49b49e5dbd6f9ffbe4ee,
title = "Spinal Cord Ependymomas With MYCN Amplification Show Aggressive Clinical Behavior",
abstract = "Adult spinal cord ependymomas are typically low grade and have a relatively favorable clinical course following gross total resection. We report 4 cases of anaplastic spinal cord ependymoma with MYCN amplification, an exceptionally rare finding. All cases occurred in the spinal cord of adolescent and young adult women and had morphological and immunohistochemical features of anaplastic ependymomas (World Health Organization grade III). Chromosomal microarray analysis demonstrated amplification of 2p24 (including MYCN) in all cases. One patient died 6 months after surgery. Another patient recently had removal of metastatic nodules in the thoracic region, following gross total resection and adjuvant radiation therapy of a lumbar ependymoma 1 year previously. One patient responded well after chemotherapy but died after multiple relapses 82 months after diagnosis. We found MYCN amplification reported in 2 other ependymomas, both anaplastic and arising in the spinal cord of adult females (Brain Pathol 2001;11:133-43). One patient had multiple recurrences in the spinal cord and an intracranial metastasis. Although MYCN amplification is rare in ependymomas, the current and previously reported cases suggest that this is associated with higher-grade histology, spinal location, and often unfavorable prognosis. The clinical significance and therapeutic implications of MYCN amplification in ependymomas require further evaluation.",
keywords = "Anaplastic ependymoma, Ependymoma, MYCN amplification, Spinal cord",
author = "Swanson, {Amy A.} and Aditya Raghunathan and Jenkins, {Robert Brian} and Martina Messing-J{\"u}nger and Torsten Pietsch and Clarke, {Michelle J.} and Kaufmann, {Timothy J} and Caterina Giannini",
year = "2019",
month = "9",
day = "1",
doi = "10.1093/jnen/nlz064",
language = "English (US)",
volume = "78",
pages = "791--797",
journal = "American Journal of Psychotherapy",
issn = "0002-9564",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Spinal Cord Ependymomas With MYCN Amplification Show Aggressive Clinical Behavior

AU - Swanson, Amy A.

AU - Raghunathan, Aditya

AU - Jenkins, Robert Brian

AU - Messing-Jünger, Martina

AU - Pietsch, Torsten

AU - Clarke, Michelle J.

AU - Kaufmann, Timothy J

AU - Giannini, Caterina

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Adult spinal cord ependymomas are typically low grade and have a relatively favorable clinical course following gross total resection. We report 4 cases of anaplastic spinal cord ependymoma with MYCN amplification, an exceptionally rare finding. All cases occurred in the spinal cord of adolescent and young adult women and had morphological and immunohistochemical features of anaplastic ependymomas (World Health Organization grade III). Chromosomal microarray analysis demonstrated amplification of 2p24 (including MYCN) in all cases. One patient died 6 months after surgery. Another patient recently had removal of metastatic nodules in the thoracic region, following gross total resection and adjuvant radiation therapy of a lumbar ependymoma 1 year previously. One patient responded well after chemotherapy but died after multiple relapses 82 months after diagnosis. We found MYCN amplification reported in 2 other ependymomas, both anaplastic and arising in the spinal cord of adult females (Brain Pathol 2001;11:133-43). One patient had multiple recurrences in the spinal cord and an intracranial metastasis. Although MYCN amplification is rare in ependymomas, the current and previously reported cases suggest that this is associated with higher-grade histology, spinal location, and often unfavorable prognosis. The clinical significance and therapeutic implications of MYCN amplification in ependymomas require further evaluation.

AB - Adult spinal cord ependymomas are typically low grade and have a relatively favorable clinical course following gross total resection. We report 4 cases of anaplastic spinal cord ependymoma with MYCN amplification, an exceptionally rare finding. All cases occurred in the spinal cord of adolescent and young adult women and had morphological and immunohistochemical features of anaplastic ependymomas (World Health Organization grade III). Chromosomal microarray analysis demonstrated amplification of 2p24 (including MYCN) in all cases. One patient died 6 months after surgery. Another patient recently had removal of metastatic nodules in the thoracic region, following gross total resection and adjuvant radiation therapy of a lumbar ependymoma 1 year previously. One patient responded well after chemotherapy but died after multiple relapses 82 months after diagnosis. We found MYCN amplification reported in 2 other ependymomas, both anaplastic and arising in the spinal cord of adult females (Brain Pathol 2001;11:133-43). One patient had multiple recurrences in the spinal cord and an intracranial metastasis. Although MYCN amplification is rare in ependymomas, the current and previously reported cases suggest that this is associated with higher-grade histology, spinal location, and often unfavorable prognosis. The clinical significance and therapeutic implications of MYCN amplification in ependymomas require further evaluation.

KW - Anaplastic ependymoma

KW - Ependymoma

KW - MYCN amplification

KW - Spinal cord

UR - http://www.scopus.com/inward/record.url?scp=85071702889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071702889&partnerID=8YFLogxK

U2 - 10.1093/jnen/nlz064

DO - 10.1093/jnen/nlz064

M3 - Article

C2 - 31373367

AN - SCOPUS:85071702889

VL - 78

SP - 791

EP - 797

JO - American Journal of Psychotherapy

JF - American Journal of Psychotherapy

SN - 0002-9564

IS - 9

ER -